Pfenex Inc. Announces Formation of Scientific Advisory Board

14:14 EDT 19 Oct 2016 | PR Newswire
This article has expired, however you can still download the PDF.
SAN DIEGO, Oct. 19, 2016 /PRNewswire/ -- Pfenex Inc., a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics and high-value, difficult to manufacture proteins, today announced the development of a Scientific Advis...

Other Sources for this Article


More From BioPortfolio on "Pfenex Inc. Announces Formation of Scientific Advisory Board"

Quick Search

Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...